Prior studies have linked PDCD1LG2 to AD risk and age of onset (Herold et al. 2016), while NRG3 has been associated with both AD (Herold et al. 2016; Lee et al. 2022) and other neurodegenerative conditions (Tian et al. 2021). This evidence concerns the gene NRG3 and Alzheimer disease.